MDNAF Medicenna Therapeutics
- 1.110
- -0.005-0.45%
Medicenna Therapeutics News
Medicenna Therapeutics | 15-12G: Notice of termination of registration of a class of securities under Section 12(g) (and amendment thereto)
Medicenna Therapeutics | D: Filing D
Medicenna Therapeutics | EFFECT: Others
Medicenna Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Medicenna Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-RA Capital Management, L.P.(9.99%),Peter Kolchinsky(9.99%), etc.
Medicenna Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Medicenna Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Medicenna Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Medicenna Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Medicenna Therapeutics | AW: Withdrawal of amendment to a registration statement filed under the Securities Act
Medicenna Therapeutics | F-10POS: Others
Medicenna Therapeutics | F-3/A: Registration statement for specified transactions by certain foreign private issuers (Amendment)
Medicenna Therapeutics | S-8 POS: S-8 POS
Medicenna Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Medicenna Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Medicenna Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Medicenna Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Medicenna Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Fahar Merchant(29.1%),Rosemina Merchant(29.1%), etc.
Medicenna Therapeutics | 6-K: Report of foreign private issuer (related to financial reporting)
Medicenna Therapeutics | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
No Data